Lillys CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise
Lilly’s CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise
13:32 EST 6 Nov 2018 |
SCRIP
Lilly reported strong sales growth for many of its recently launched products, but news of the potentially differentiating REWIND cardiovascular...
More From BioPortfolio on "Lilly’s CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise"